Home | Welcome to Contract Pharma   
Last Updated Thursday, April 24 2014
Print RSS Feed

Breaking News

Related Searches:
May 18, 2010
Revotar Biopharmaceuticals achieved positive results in Phase IIa Ozone Study with Bimosiamose for COPD.   Read More »
May 17, 2010
Astellas Pharma and OSI Pharmaceuticals have entered into a merger agreement under which Astellas will acquire OSI for approximately $4.0 billion in cash.   Read More »
May 17, 2010
David Spaight has been appointed chief executive officer of WIL Research Co.   Read More »
May 17, 2010
NeoPharm, Inc.’s IL13-PE38QQR (IL13-PE) has been granted orphan drug designation by the FDA for the treatment of Idiopathic Pulmonary Fibrosis (IPF).  Read More »
May 14, 2010
Anthony S. Chilton, Ph.D., has been appointed president and chief executive officer of Bioanalytical Systems, Inc.  Read More »
May 14, 2010
Mikel Moyer, Ph.D., has been named vice president of Molecular Discovery at Epizyme, Inc.   Read More »
May 14, 2010
Neotropix began enrolling patients in a Phase II trial to assess the efficacy of the novel oncolytic virus, NTX-010, in patients with extensive stage small cell lung cancer (SCLC).  Read More »
May 13, 2010
PAREXEL International Corp. has opened offices in Chengdu and Guangzhou, China to support a broad range of clinical development and regulatory consulting services throughout the Asia/Pacific region.  Read More »
May 13, 2010
Lonza Group Ltd. has signed an agreement to acquire MODA Technology Partners, a software company that provides paperless quality control solutions.  Read More »
May 13, 2010
Q Laboratories, Inc. has achieved ISO/IEC 17025 Accreditation from the American Association of Laboratory Accreditation (A2LA) for multiple microbiological and analytical chemistry methods.  Read More »
May 13, 2010
Chimerix, Inc. has initiated a Phase I study of CMX157, a novel lipid conjugate of the nucleotide tenofovir with in vitro activity against both tenofovir-sensitive and tenofovir-resistant human immunodeficiency virus (HIV).  Read More »
May 12, 2010
Elliott Berger has been appointed vice president of Global Marketing and Strategy for Catalent Pharma Solutions.   Read More »
May 12, 2010
Pfizer and Ergonex Pharma GmbH have entered into an agreement under which Pfizer will acquire terguride, an oral, potent antagonist of 5-HT2B and 5-HT2A (serotonin) receptors, in development for Pulmonary Arterial Hypertension (PAH).  Read More »
May 12, 2010
Eisai Inc., a U.S. subsidiary of Eisai Co., Ltd., headquartered in Tokyo, has established a wholly-owned subsidiary Eisai Ltd. in Mississauga, Ontario.   Read More »
May 12, 2010
QPharma, Inc. has integrated its sample accountability and distribution applications into the Veeva Web, a SaaS CRM application network for life sciences companies.  Read More »

Receive free Contract Pharma Direct emails
Sign up now to receive the weekly newsletter, and more!

Enter your email address:
Follow Contract Pharma On